文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

癌症患者微生物群的生态管理。

Ecological management of the microbiota in patients with cancer.

作者信息

Xavier Joao B

机构信息

Program for Computational and Systems Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

Nat Rev Clin Oncol. 2025 Jun 27. doi: 10.1038/s41571-025-01049-3.


DOI:10.1038/s41571-025-01049-3
PMID:40579430
Abstract

The composition of the intestinal microbiota influences the outcomes of patients receiving cancer treatment, although the best way to use this knowledge to improve cancer care remains unclear. In this Review, I synthesize the current understanding of host-microbiota dynamics in patients with cancer, and propose the integration of microbiota management guided by ecological principles in cancer care. Ecological management of the microbiota emphasizes the preservation of microbial populations - and the benefits they provide to the host - from the disruption caused by treatments such as chemotherapy and prophylactic antibiotics. The microbiota can be routinely and longitudinally monitored in patients using proven non-invasive methods, such as 16S ribosomal RNA amplicon sequencing. Longitudinal microbiome data can be processed with innovative computational tools based on principles of mathematical ecology to predict the risk of microbiota-related complications, guide treatment choices that minimize disturbance to the microbiota and restore microbial populations damaged by cancer treatment. Routine microbiome monitoring could also generate extensive datasets for human-based research, which could inform new microbiota-targeted interventions that improve responses to cancer treatments, including immune-checkpoint inhibitors. Applying ecological approaches to manage microbiota could enhance cancer care and improve patient outcomes.

摘要

肠道微生物群的组成会影响接受癌症治疗患者的治疗结果,尽管利用这一知识改善癌症护理的最佳方法仍不明确。在本综述中,我总结了目前对癌症患者体内宿主-微生物群动态的理解,并提议在癌症护理中纳入以生态学原理为指导的微生物群管理。微生物群的生态管理强调保护微生物种群及其为宿主带来的益处,使其免受化疗和预防性抗生素等治疗造成的破坏。可使用经过验证的非侵入性方法(如16S核糖体RNA扩增子测序)对患者的微生物群进行常规和纵向监测。纵向微生物组数据可通过基于数学生态学原理的创新计算工具进行处理,以预测微生物群相关并发症的风险,指导选择对微生物群干扰最小的治疗方法,并恢复因癌症治疗而受损的微生物种群。常规微生物组监测还可为基于人类的研究生成大量数据集,从而为新的以微生物群为靶点的干预措施提供依据,这些干预措施可改善对癌症治疗(包括免疫检查点抑制剂)的反应。应用生态学方法管理微生物群可加强癌症护理并改善患者治疗结果。

相似文献

[1]
Ecological management of the microbiota in patients with cancer.

Nat Rev Clin Oncol. 2025-6-27

[2]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[3]
Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.

Cochrane Database Syst Rev. 2014-4-29

[4]
Systemic treatments for metastatic cutaneous melanoma.

Cochrane Database Syst Rev. 2018-2-6

[5]
Management of urinary stones by experts in stone disease (ESD 2025).

Arch Ital Urol Androl. 2025-6-30

[6]
Developing evidence-based guidelines for describing potential benefits and harms within patient information leaflets/sheets (PILs) that inform and do not cause harm (PrinciPILs).

Health Technol Assess. 2025-8

[7]
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Health Technol Assess. 2006-9

[8]
Integrating microbiome science and evolutionary medicine into animal health and conservation.

Biol Rev Camb Philos Soc. 2024-4

[9]
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.

Cochrane Database Syst Rev. 2022-10-4

[10]
Effect of antibiotics on the human microbiome: a systematic review.

Int J Antimicrob Agents. 2022-2

引用本文的文献

[1]
Intratumoral microbiota: implications for cancer progression and treatment.

Front Microbiol. 2025-7-28

本文引用的文献

[1]
The physical biogeography of in health and disease.

mBio. 2025-4-9

[2]
Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease.

Liver Res. 2021-9-2

[3]
The role of bacteriophages in facilitating the horizontal transfer of antibiotic resistance genes in municipal wastewater treatment plants.

Water Res. 2025-1-1

[4]
VFDB 2025: an integrated resource for exploring anti-virulence compounds.

Nucleic Acids Res. 2025-1-6

[5]
A core microbiome signature as an indicator of health.

Cell. 2024-11-14

[6]
Antifungal heteroresistance causes prophylaxis failure and facilitates breakthrough Candida parapsilosis infections.

Nat Med. 2024-11

[7]
Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome.

Cell. 2024-6-20

[8]
Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer.

Cell. 2024-3-28

[9]
Altered microbial bile acid metabolism exacerbates T cell-driven inflammation during graft-versus-host disease.

Nat Microbiol. 2024-3

[10]
Alterations in colorectal cancer virome and its persistence after surgery.

Sci Rep. 2024-2-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索